Related references
Note: Only part of the references are listed.Immunological alterations in newly diagnosed primary Sjogren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines
P. Szodoray et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2008)
The role of interleukin-10 promoter polymorphisms in primary Sjogren's syndrome
P. Willeke et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2008)
Interleukin 6: from bench to bedside
Norihiro Nishimoto et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Quality of life and psychological status in patients with primary Sjogren's syndrome and sicca symptoms without autoimmune features
Julien Champey et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome
A Hartkamp et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Circulating cytokines in primary Sjogren's syndrome determined by a multiplex cytokine array system
P Szodoray et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia
C Sommer et al.
NEUROSCIENCE LETTERS (2004)
The role of interleukin-6 in nociception and pain
RF De Jongh et al.
ANESTHESIA AND ANALGESIA (2003)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo
SD Mathias et al.
CLINICAL THERAPEUTICS (2000)
Share Paper
